Caribou Biosciences CRBU
NASDAQ CRBU
$1.22 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Caribou Biosciences (CRBU) Cash from Investing Activities (2020 - 2026)

Updated

Caribou Biosciences' Cash from Investing Activities was $18.94 million in Q2 2026, down 21.2% from $24.04 million a year earlier and down 21.0% from the prior quarter.

Analysis

Caribou Biosciences (CRBU) Cash from Investing Activities (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Caribou Biosciences' Cash from Investing Activities was $71.75 million through Jun 30, 2026, down 38.1% year-over-year; for FY2025, it came in at $102.24 million, up 18.0% from FY2024.

  • Cash from Investing Activities shows a five-year compound annual growth rate of 74.3% (FY2020 to FY2025).
  • In earlier years, Cash from Investing Activities was $86.61 million in FY2024, -$68.18 million in FY2023, -$93.25 million in FY2022 and -$176.4 million in FY2021.
  • Quarterly Cash from Investing Activities has moved between -$173.96 million (Q4 2021) and $49.38 million (Q1 2025) over five years.
  • Compared with a year earlier, Cash from Investing Activities was higher in three of the last six quarters, with growth averaging 1.6%.
  • The best year-over-year quarter for Cash from Investing Activities over five years was Q1 2025 (growth of 115.1%); the worst was Q3 2025 (a decline of 59.1%).
  • Per Business Quant data, CRBU's Cash from Investing Activities in the three quarters before Q2 2026 was $23.99 million (Q1 2026), $17.97 million (Q4 2025) and $10.85 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -1.11 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.91 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.35 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.11 Bn
10 Caribou Biosciences 129.31 Mn -387.22 Mn - 18.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.94 Mn
Mar 31, 2026 23.99 Mn
Dec 31, 2025 17.97 Mn
Sep 30, 2025 10.85 Mn
Jun 30, 2025 24.04 Mn
Mar 31, 2025 49.38 Mn
Dec 31, 2024 15.93 Mn
Sep 30, 2024 26.52 Mn
Jun 30, 2024 21.20 Mn
Mar 31, 2024 22.96 Mn
Dec 31, 2023 -31.47 Mn
Sep 30, 2023 -68.48 Mn
Jun 30, 2023 11.06 Mn
Mar 31, 2023 20.70 Mn
Dec 31, 2022 1.17 Mn
Sep 30, 2022 -8.34 Mn
Jun 30, 2022 -13.97 Mn
Mar 31, 2022 -72.11 Mn
Dec 31, 2021 -173.96 Mn
Sep 30, 2021 -1.93 Mn
API Access

Caribou Biosciences Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=CRBU&period=max&api_key=YOUR_API_KEY